These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
417 related articles for article (PubMed ID: 25022891)
1. Outpatient parenteral antimicrobial therapy for infective endocarditis: a cost-effective strategy. Lacroix A; Revest M; Patrat-Delon S; Lemaître F; Donal E; Lorléac'h A; Arvieux C; Michelet C; Tattevin P Med Mal Infect; 2014 Jul; 44(7):327-30. PubMed ID: 25022891 [TBL] [Abstract][Full Text] [Related]
2. Outpatient parenteral antibiotic therapy for infective endocarditis: a review of 4 years' experience at a UK centre. Partridge DG; O'Brien E; Chapman AL Postgrad Med J; 2012 Jul; 88(1041):377-81. PubMed ID: 22366395 [TBL] [Abstract][Full Text] [Related]
3. Self-administered outpatient parenteral antimicrobial therapy (S-OPAT) for infective endocarditis: a safe and effective model. Pajarón M; Fernández-Miera MF; Allende I; Arnaiz AM; Gutiérrez-Cuadra M; Cobo-Belaustegui M; Armiñanzas C; de Berrazueta JR; Fariñas MC; Sanroma P; Eur J Intern Med; 2015 Mar; 26(2):131-6. PubMed ID: 25596808 [TBL] [Abstract][Full Text] [Related]
4. Costs of outpatient parenteral antimicrobial therapy (OPAT) administered by Hospital at Home units in Spain. González-Ramallo VJ; Mirón-Rubio M; Mujal A; Estrada O; Forné C; Aragón B; Rivera AJ Int J Antimicrob Agents; 2017 Jul; 50(1):114-118. PubMed ID: 28499957 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of outpatient parenteral antibiotic therapy for infective endocarditis: a ten-year prospective study. Cervera C; del Río A; García L; Sala M; Almela M; Moreno A; Falces C; Mestres CA; Marco F; Robau M; Gatell JM; Miró JM; Enferm Infecc Microbiol Clin; 2011 Oct; 29(8):587-92. PubMed ID: 21723004 [TBL] [Abstract][Full Text] [Related]
6. Mandatory infectious diseases approval of outpatient parenteral antimicrobial therapy (OPAT): clinical and economic outcomes of averted cases. Conant MM; Erdman SM; Osterholzer D J Antimicrob Chemother; 2014 Jun; 69(6):1695-700. PubMed ID: 24532684 [TBL] [Abstract][Full Text] [Related]
7. [Outpatient parenteral antimicrobial therapy (OPAT) in bone and joint infections]. Galpérine T; Ader F; Piriou P; Judet T; Perronne C; Bernard L Med Mal Infect; 2006 Mar; 36(3):132-7. PubMed ID: 16580802 [TBL] [Abstract][Full Text] [Related]
8. Efficiency of a self-administered outpatient parenteral antimicrobial therapy (s-opat) for infective endocarditis within the context of a shortened hospital admission based on hospital at home program. Pajarón M; Lisa M; Fernández-Miera MF; Dueñas JC; Allende I; Arnaiz AM; Sanroma-Mendizábal P; De Berrazueta JR; Fariñas MC; Hosp Pract (1995); 2017 Dec; 45(5):246-252. PubMed ID: 29090606 [TBL] [Abstract][Full Text] [Related]
9. Cost-utility analysis of outpatient parenteral antimicrobial therapy (OPAT) in the Brazilian national health system. Psaltikidis EM; Silva END; Moretti ML; Trabasso P; Stucchi RSB; Aoki FH; Cardoso LGO; Höfling CC; Bachur LF; Ponchet DDF; Colombrini MRC; Tozzi CS; Ramos RF; Costa SMQ; Resende MR Expert Rev Pharmacoecon Outcomes Res; 2019 Jun; 19(3):341-352. PubMed ID: 30362845 [TBL] [Abstract][Full Text] [Related]
10. Simulated Cost-effectiveness and Long-term Clinical Outcomes of Addiction Care and Antibiotic Therapy Strategies for Patients With Injection Drug Use-Associated Infective Endocarditis. Adams JW; Savinkina A; Hudspeth JC; Gai MJ; Jawa R; Marks LR; Linas BP; Hill A; Flood J; Kimmel S; Barocas JA JAMA Netw Open; 2022 Feb; 5(2):e220541. PubMed ID: 35226078 [TBL] [Abstract][Full Text] [Related]
11. Outpatient parenteral antimicrobial therapy is safe and effective for the treatment of infective endocarditis: a retrospective cohort study. Htin AK; Friedman ND; Hughes A; O'Brien DP; Huffam S; Redden AM; Athan E Intern Med J; 2013 Jun; 43(6):700-5. PubMed ID: 23347167 [TBL] [Abstract][Full Text] [Related]
12. Self-Administered Outpatient Antimicrobial Infusion by Uninsured Patients Discharged from a Safety-Net Hospital: A Propensity-Score-Balanced Retrospective Cohort Study. Bhavan KP; Brown LS; Haley RW PLoS Med; 2015 Dec; 12(12):e1001922. PubMed ID: 26671467 [TBL] [Abstract][Full Text] [Related]
13. Outcomes and cost minimisation associated with outpatient parenteral antimicrobial therapy (OPAT) for foot infections in people with diabetes. Malone M; West D; Xuan W; Lau NS; Maley M; Dickson HG Diabetes Metab Res Rev; 2015 Sep; 31(6):638-45. PubMed ID: 25850572 [TBL] [Abstract][Full Text] [Related]
15. Outpatient parenteral antimicrobial therapy at large Veterans Administration medical center. Lai A; Tran T; Nguyen HM; Fleischmann J; Beenhouwer DO; Graber CJ Am J Manag Care; 2013 Sep; 19(9):e317-24. PubMed ID: 24449959 [TBL] [Abstract][Full Text] [Related]
16. Supervised self-administration of outpatient parenteral antibiotic therapy: a report from a large tertiary hospital in Australia. Subedi S; Looke DF; McDougall DA; Sehu MM; Playford EG Int J Infect Dis; 2015 Jan; 30():161-5. PubMed ID: 25603999 [TBL] [Abstract][Full Text] [Related]
17. A cost analysis of Outpatient Parenteral Antibiotic Therapy (OPAT): an Asian perspective. Yong C; Fisher DA; Sklar GE; Li SC Int J Antimicrob Agents; 2009 Jan; 33(1):46-51. PubMed ID: 18823759 [TBL] [Abstract][Full Text] [Related]
18. Outpatient parenteral antimicrobial therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years. Matthews PC; Conlon CP; Berendt AR; Kayley J; Jefferies L; Atkins BL; Byren I J Antimicrob Chemother; 2007 Aug; 60(2):356-62. PubMed ID: 17566002 [TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics and outcomes of patients receiving outpatient parenteral antibiotic therapy in a Belgian setting: a single-center pilot study. Briquet C; Cornu O; Servais V; Blasson C; Vandeleene B; Yildiz H; Stainier A; Yombi JC Acta Clin Belg; 2020 Aug; 75(4):275-283. PubMed ID: 31023169 [TBL] [Abstract][Full Text] [Related]